Related Experiment Video
Updated: Jul 17, 2025

06:54
A Model for Encephalomyosynangiosis Treatment after Middle Cerebral Artery Occlusion-Induced Stroke in Mice
Published on: June 22, 2022
2.8K
Cervical dumbbell-type tumor spontaneously shrinking following an ischemic stroke
Kota Nakajima1, Yoshinori Maki2, Toshinari Kawasaki3
1Department of Neurosurgery, Kobe City Medical Center General Hospital, Kobe, Japan.
Surgical Neurology International
|September 8, 2023
Summary
A 57-year-old man with an asymptomatic cervical dumbbell schwannoma experienced tumor shrinkage after a stroke. This spontaneous regression relieved spinal cord and vertebral artery compression.
Area of Science:
- Neurosurgery
- Radiology
- Oncology
Background:
- Cervical dumbbell-type tumors are often incidentally diagnosed and asymptomatic.
- The natural history and chronological changes in size of these tumors remain poorly understood.
- Spinal schwannomas can present as dumbbell-type lesions, extending through neural foramina.
Observation:
- A 57-year-old male patient was monitored for a 7-year period for an asymptomatic cervical dumbbell tumor.
- Magnetic resonance (MR) imaging revealed the tumor, suspected to be a schwannoma, compressing the spinal cord and right vertebral artery.
- The patient suffered a cerebral infarction due to right vertebral artery atherosclerosis, with imaging confirming tumor compression of the artery.
Findings:
- Following the cerebral infarction, the cervical dumbbell tumor exhibited spontaneous shrinkage over 4 years on serial MR imaging.
- The tumor's regression led to a significant relief of both spinal cord and right vertebral artery compression.
- This case documents the first reported instance of spontaneous tumor regression following a cerebrovascular event.
Implications:
- This case suggests a potential link between cerebrovascular events and the regression of certain spinal tumors.
- Further research is warranted to explore the mechanisms underlying spontaneous tumor shrinkage.
- Understanding such phenomena could offer novel therapeutic insights for managing spinal tumors.

